ConductScience.org, home

Paper39201609

Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets.

Campagnoli LIM and 9 others. Int J Mol Sci, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets. Papers, record 39201609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.45, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Protein Kinase C betaMajor topic
Multiple SclerosisMajor topic
Antibodies, Monoclonal, HumanizedMajor topic
Humans
Female
Male
Adult
Middle Aged
Vascular Endothelial Growth Factor A
Hypoxia-Inducible Factor 1, alpha Subunit
Leukocytes, Mononuclear
Superoxide Dismutase

Source PubMed

Download CSV of topics

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119900507Role of PKCbetaII and PKCdelta in blood-brain barrier permeability during aglycemic hypoxia.Neurosci Lett2010https://conductscience.org/library/papers/19900507PubMed
222300081Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing.Curr Med Chem2012https://conductscience.org/library/papers/22300081PubMed
330813635Mechanisms of PKC-Mediated Enhancement of HIF-1α Activity and its Inhibition by Vitamin K2 in Hepatocellular Carcinoma Cells.Int J Mol Sci2019https://conductscience.org/library/papers/30813635PubMed
429774057Ocrelizumab: a new milestone in multiple sclerosis therapy.Ther Adv Neurol Disord2018https://conductscience.org/library/papers/29774057PubMed
536046820Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: a new option to target early stages of diabetic retinopathy?Front Pharmacol2022https://conductscience.org/library/papers/36046820PubMed
620700133Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation.J Cereb Blood Flow Metab2010https://conductscience.org/library/papers/20700133PubMed
735981507Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis.Neuroimmunomodulation2022https://conductscience.org/library/papers/35981507PubMed
88756616Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.Mol Cell Biol1996https://conductscience.org/library/papers/8756616PubMed
920197783Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.J Cereb Blood Flow Metab2010https://conductscience.org/library/papers/20197783PubMed
1030300457Multiple sclerosis - a review.Eur J Neurol2019https://conductscience.org/library/papers/30300457PubMed
1132682869Treatment of Multiple Sclerosis: A Review.Am J Med2020https://conductscience.org/library/papers/32682869PubMed
1225257521Farm animal serum proteomics and impact on human health.Int J Mol Sci2014https://conductscience.org/library/papers/25257521PubMed
1317083617Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis.Scand J Immunol2006https://conductscience.org/library/papers/17083617PubMed
147897234Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system.J Immunol1995https://conductscience.org/library/papers/7897234PubMed
1524328534Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients.Autoimmunity2014https://conductscience.org/library/papers/24328534PubMed
1614664465Blood-brain barrier disruption in multiple sclerosis.Mult Scler2003https://conductscience.org/library/papers/14664465PubMed
1738568026Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.Ann Neurol2024https://conductscience.org/library/papers/38568026PubMed
1829686116
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology2018https://conductscience.org/library/papers/29686116PubMed
1938553104Relationship between inflammation and oxidative stress and its effect on multiple sclerosis.Neurologia (Engl Ed)2024https://conductscience.org/library/papers/38553104PubMed
2032200342Unraveling a new player in multiple sclerosis pathogenesis: The RNA-binding protein HuR.Mult Scler Relat Disord2020https://conductscience.org/library/papers/32200342PubMed

See all 58 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42632066Sex- and age-specific associations of VEGFA polymorphisms with multiple sclerosis susceptibility.Ann Med2026https://conductscience.org/library/papers/42632066PubMed
40722952Manganese Superoxide Dismutase: Structure, Function, and Implications in Human Disease.Antioxidants (Basel)2025https://conductscience.org/library/papers/40722952PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ELAVL11994PubTator's text mininghttps://conductscience.org/library/genes/1994NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
HSPA43308PubTator's text mininghttps://conductscience.org/library/genes/3308NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
PRKCB5579PubTator's text mininghttps://conductscience.org/library/genes/5579NCBI Gene
PRRT2112476PubTator's text mininghttps://conductscience.org/library/genes/112476NCBI Gene
SOD26648PubTator's text mininghttps://conductscience.org/library/genes/6648NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39201609

GET https://conductscience.org/api/papers/v1/39201609/references?page=2